The purpose of this award is to encourage and support academic research in sciences related to the investigation of otology and neurotology.
Appropriate areas of research include diagnosis, management, and pathogenesis of diseases of the neurological conditions. The award is open to both basic and clinical research. Topics could range from tinnitus, balance, infection, hearing loss, tumors and other otology related issues any many other neurological condition.The research may
Appropriate areas of research include diagnosis, management, and pathogenesis of diseases of the neurological conditions. The award is open to both basic and clinical research. Topics could range from tinnitus, balance, infection, hearing loss, tumors and other otology related issues any many other neurological condition.The research may involve cell/molecular studies, animal research, human subjects and clinical research.
The award amount is 2000 USD, and will be presented in January 2024. Applications for the 2023 award will be accepted beginning April 2023. The application should include the applicant's CV, abstract of the research, and the method of research and results. The method section should be as detailed as possible. and references must be inc
The award amount is 2000 USD, and will be presented in January 2024. Applications for the 2023 award will be accepted beginning April 2023. The application should include the applicant's CV, abstract of the research, and the method of research and results. The method section should be as detailed as possible. and references must be included. The applicant must clearly explain his role if there is more than one researcher involved in the project. If published or presented academically, date and place should be included.
We also consider applicants whom do not have publications to submit to our committee. Applicant could be doing things to community that is beyond publications. These could be nurses, surgical techs whom facilitates the ear surgeries for years to number of ear surgeons. Audiologist working in low in-come community and provide service to low in come community. These are few examples, our goal is to recognize the individuals whom does good to humanity.
Please send your application through bmamikog@gmail.com. We would like to thank all the applicants.
What's something exciting your business offers? Say it here.
We received four studies from four different researchers. The committee reviewed the studies without knowing the name of the researcher.
The evaluations is assessed as follows
The president of the award committee is Prof. Nuri Özgirgin. Prof Armağan Incesulu is Members. The secretary of committee is Prof. Dr Güven Mengü.
In 1963 after completing his residency training in West Germany, Dr Mamikoglu brought an OPMI -1 Zeiss microscope to Ankara with him. At the time there were no surgical microscopes in Ankara Numune Hospital , the biggest Hospital in the Capital.
Musuem visitors and director of the museum Mrs. Deniz Genç posing with the microscope.
Dr. Osman Mamıkoğlu was an otolaryngologist and a pioneer otologic surgeon. He was born the tenth and last child to a mid Anatolian family in 1928. He competed otolaryngology training in Ankara, West Berlin, Essen and Munich. He returned to Turkey in 1964, and began his career at Ankara Numune Research Hospital. He served as Chief of Otolaryngology of the same hospital between 1972-1979 and remained as a private practitioner until his retirement on 2002. Dr.Mamıkoğlu introduced modern otologic surgical techniques to his homeland. He gained nationwide recognition, especially in regards to chronic otitis surgeries. Throughout his career he emphasized the importance of surgical anatomy, respecting middle ear mucosa, following literature and maintaining good relationships with colleagues. He advocated listening to patients and understanding what they really need. We miss him as a clinician, and as someone who dedicated his life to helping others.
Dr Tankut Uzun had been presented on March 17, 2021 at Eskisehir with scientific committee's "recognition award" for about his research on In Vitro Study on Immune Response Modifiers as Novel Medical Treatment Options for Cholesteatoma
The award committee completed their review about the studies submitted for 2019 award. The award committee decided that BACTERIAL CELLULOSE TUBES AS A NERVE CONDUIT FOR REPAIRING COMPLETE FACIAL NERVE TRANSECTION IN A RAT MODEL study submitted by Dr. Berat Demir as the winner of this year‘s award. We congratulate him, his award will be presented to him on January 17, 2020 in Ankara Bayindir Hospital. We also thank to all other applicants for submitting their original works for consideration for this award.
Abstract
Introduction: Cholesteatoma is a mass consisting of keratinized squamous epithelium and subepithelial connective tissue fragments inside the tympanic or mastoid cavity. Cholesteatoma attacks bone progressively, creates continuous inflammation, and causes significant complications including meningitis. Although many theories have been produced to explain the etiopathogenesis of cholesteatoma, the main pathogenetic components are still unknown. In our study, we observed the immunomodulatory effects of various immune response modifier drugs on cholesteatoma and demonstrated their effects on proliferation in cell culture.
Methods: To observe the pathogenesis of cholesteatoma and to apply the immunomodulatory drugs, cholesteatoma tissue culture models were constituted with HEKa cells and cholesteatoma keratinocytes, which were obtained from three patients who underwent operations for cholesteatoma. Medicines including 5-fluorourasil, imiquimod, cyclosporine, and tacrolimus were applied on both cholesteatoma keratinocytes and HEKa cells. After 48 hours of incubation, IL-1, IL-6, IL-8, IL-10, TNF-α, and Ki67 levels were measured to determine cell viability rates.
Results: In the cholesteatoma control group, IL-6 and TNF-α levels were found higher than in the HEKa control group. All repurposed drugs in the study demonstrated anti-inflammatory, anti-proliferative, and cytotoxic effects on cholesteatoma. Imiquimod and tacrolimus in particular are potential treatment prospects for cholesteatoma due to their strong anti-inflammatory and cytotoxic effects.
Conclusion: Medical therapy options for cholesteatoma are still missing and surgery is not the ultimate solution. We have focused on intercellular inflammatory processes, which play significant roles in the pathogenesis of cholesteatoma in our paper. Inflammation and proliferation of cholesteatoma decreased after all repurposed drug applications in our study. Anti-inflammatory and anti-proliferative effects of tacrolimus and imiquimod was more significant than other drugs in the study. For this reason, tacrolimus and imiquimod should be examined in depth with in vivo studies in terms of efficacy and safety for medical treatment of cholesteatoma.
The ceremony was held on March 17, 2021 at the University of Eskisehir Osmangazi, Department of Otolaryngology, and award was presented by Prof Armagan Incesulu to Dr. Uzun.
Dr. Berat Demir won the 2019 award with his study about BACTERIAL CELLULOSE TUBES AS A NERVE CONDUIT FOR REPAIRING COMPLETE FACIAL NERVE TRANSECTION IN A RAT MODEL
Purpose: Functionality of the facial nerve is cosmetically important. While many techniques have been investigated, early and effective treatment for traumatic facial nerve paralysis
remains challenging. Here, we aim to examine bacterial cellulose (BC) as a new tubularization material for improving facial nerve regeneration.
Methods: Our study was performed on 40 female Sprague Dawley rats. Rats were randomly
divided into four groups, with 10 rats per group. In all rats, the main trunk of the facial nerve was completely cut 8 mm before the branching point. For repairing the facial nerve, in group 1,
the nerve was left to recover spontaneously (control group); in group 2, it was repaired by primary suturing (8.0 Ethilon sutures, Ethicon); in group 3, BC tubes alone were used to aid
nerve repair; and in group 4, both BC tubes and primary sutures (8.0 Ethilon sutures) were used.
After 10 weeks, the facial nerve regeneration was evaluated by the whisker movement test and electrophysiologically (nerve stimulation threshold and compound muscle action potential).
Nerve regeneration was assessed by calculating the number of myelinated nerve fibers, and by microscopically evaluating the amount of regeneration and fibrosis.
Results: No significant difference was observed among the groups in terms of whisker
movement and electrophysiological parameters (P > 0.05). We found the numbers of regenerating myelinated fibers were significantly increased (P < 0.05) when BC tubes were
used as a nerve conduit.
Conclusions: BC can be easily shaped into a hollow tube that guides nerve axons, resulting in
better nerve regeneration after transection.
Your support and contributions will enable us to meet our goals and improve conditions. Your generous donation will fund our mission.
Copyright © 2023 www.mamikoglu.org - All Rights Reserved.
Powered by GoDaddy